Welcome to the Ovarian Cancer Studies Page

CURRENT STUDIES THAT MAY INTEREST YOU

MyPaTH Story Booth – COVID-19 Stories

Participants are invited to share how they are maintaining their health during the coronavirus pandemic, or to share what it is like being ill with COVID-19 and/or caring for a loved one who is ill with COVID-19. Participation in this research study involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.

ACL Tear

DURATION: About 45 minutes

VISITS: No in-person visits

LOCATION: By phone

COMPENSATION: $10 gift card/story with a maximum of 2 stories, for a total of $20

NO IN-PERSON VISITS

Cancer and Opioids: Patient Experiences with Stigma (COPES)

Have you been diagnosed with advanced cancer and currently take prescription pain medication to treat your pain? You may be eligible to participate in a research study to develop interventions to promote safe, effective, and informed opioid pain management practices for millions of patients with cancer pain. Compensation is provided.

DURATION: Up to 5 months

VISITS: 4 online activities

LOCATION: Online

COMPENSATION: up to $80

STRONG Study

Have you recently been diagnosed with metastatic breast cancer or Stage 3 or 4 gynecological cancer? If so, you may be eligible to join a research study to discover new ways to self-advocate for a better quality of life through your cancer journey. Compensation is provided.

AGE: 18 and older

SEX ASSIGNED AT BIRTH: Female

DURATION: 6 months

VISITS: 1 remote visit and 3 remote data collection points

LOCATION: Online

COMPENSATION: $15 for each completed survey and interview

Work Limitations in Nurses with Cancer

Are you a nurse that has been diagnosed with cancer? You may be eligible for a research study to understand work experiences among nurses with cancer.

DURATION: 60 minutes

VISITS: 1 survey

LOCATION: Online

COMPENSATION: $10 Amazon gift card

All of Us Pennsylvania Research Program

All of Us wants at least one million people to join. Your participation can help shape the future of health for generations to come. People who join will share information. This might be about their health, habits, and what it’s like where they live. It might also be about family history and genes. By looking for patterns, researchers may learn more about what affects people’s health.

VISITS: one in person visit

LOCATION: Convenient locations throughout Pennsylvania

COMPENSATION: $25.00 gift card

AtTACC Pain Study – Ovarian Cancer Survivors

Are you an ovarian cancer survivor? You may be able to participate in a study to help better understand how pain changes from active disease into survivorship. This study involves wearing an activity monitor for 7 days, completing questionnaires, and one in-person study visit to UPMC Magee-Womens Hospital. Compensation is provided.

Ovarian Cancer

AGE: 45 and up

SEX ASSIGNED AT BIRTH: Female

DURATION: 1-4 weeks

VISITS: 1

LOCATION: Magee Womens Hospital Clinical and Translational Research Center (MWH CTRC) – Oakland, Online, & At home

COMPENSATION: $55

AtTACC Pain Study – Individuals with Ovarian Cancer

Do you have ovarian cancer? You may be able to participate in a study to help better understand how pain changes from active disease into survivorship. This study involves 3 sessions of wearing an activity monitor for 7 days, , completing questionnaires, and one two in-person study visit to UPMC Magee-Womens Hospital. Compensation is provided.

Ovarian Cancer

AGE: 45 and up

SEX ASSIGNED AT BIRTH: Female

DURATION: 16-184 weeks (or the length of your chemotherapy)

VISITS: 3 (2 in-person at Magee, 1 completely remote)

LOCATION: Magee Womens Hospital Clinical and Translational Research Center (MWH CTRC) – Oakland, Online, & At home

COMPENSATION: $55 for each in-person visit. $25 for each remote visit

HCC-18-006 – Ovarian Cancer Study

Have you been diagnosed with ovarian cancer that has come back after your previous treatment? If so, you may be eligible to participate in a study to help investigators evaluate the safety of a new anticancer drug, called ribociclib (LEE011). Involves receiving the study drug along with chemotherapy for 24 weeks. You will then receive the study drug by itself (maintenance dose).

Ovarian Cancer

AGE: 18 and up

SEX ASSIGNED AT BIRTH: Female

LOCATION: Magee-Women’s Hospital of UPMC

COMPENSATION: NONE

RELATED RESEARCH AREAS:

Cancer